Literature DB >> 9468026

Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.

J B Stimmel1, F C Kull.   

Abstract

We describe a simple in vitro characterization of chelation that is useful when choosing an appropriate ligand-metal combination for clinical applications. These properties include the effect of concentration on chelation efficiency, time to maximum chelation, and stability in acidic and serum environments. The macrocyclic ligands nitro-DOTA and nitro-PADOTA, the acyclic ligands nitro-CHX-A-DTPA, nitro-MX-DTPA, DTPA, and a novel terpyridine ligand, TMT-amine, were evaluated as chelate complexes of both intermediate energy beta-emitting lanthanides lutetium-177 and samarium-153. The data were compared to results obtained in a previously published study with yttrium-90. Acid lability, time to achieve maximum chelation, and stability in human serum are properties unique to each ligand-metal combination and should be evaluated prior to choosing an appropriate combination for therapeutic applications. Concentration dependence and duration of chelation are general properties of lanthanide and yttrium chelation that can be applied to an appropriate ligand-metal combination to achieve optimum chelation efficiencies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468026     DOI: 10.1016/s0969-8051(97)00151-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  10 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT).

Authors:  Nicoletta Urbano; Stefano Papi; Mauro Ginanneschi; Rita De Santis; Silvia Pace; Ragnar Lindstedt; Liliana Ferrari; Sunju Choi; Giovanni Paganelli; Marco Chinol
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-06       Impact factor: 9.236

Review 3.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

4.  Efficient route to pre-organized and linear polyaminopolycarboxylates: Cy-TTHA, Cy-DTPA and mono/di- reactive, tert-butyl protected TTHA/Cy-TTHA.

Authors:  Ali Mohamadi; Lawrence W Miller
Journal:  Tetrahedron Lett       Date:  2017-02-20       Impact factor: 2.415

Review 5.  Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.

Authors:  Eszter Boros; Jason P Holland
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

6.  H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.

Authors:  Eric W Price; Brian M Zeglis; Jacqueline F Cawthray; Caterina F Ramogida; Nicholas Ramos; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  J Am Chem Soc       Date:  2013-08-15       Impact factor: 15.419

Review 7.  Does the Number of Bifunctional Chelators Conjugated to a mAb Affect the Biological Activity of Its Radio-Labeled Counterpart? Discussion Using the Example of mAb against CD-20 Labeled with 90Y or 177Lu.

Authors:  Urszula Karczmarczyk; Agnieszka Sawicka; Piotr Garnuszek; Michał Maurin; Wioletta Wojdowska
Journal:  J Med Chem       Date:  2022-04-20       Impact factor: 8.039

8.  Oxyaapa: A Picolinate-Based Ligand with Five Oxygen Donors that Strongly Chelates Lanthanides.

Authors:  Aohan Hu; Ivan Keresztes; Samantha N MacMillan; Yang Yang; Erdong Ding; Warren R Zipfel; Robert A DiStasio; John W Babich; Justin J Wilson
Journal:  Inorg Chem       Date:  2020-03-27       Impact factor: 5.165

Review 9.  AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.

Authors:  Cyril Fersing; Nicolas Masurier; Léa Rubira; Emmanuel Deshayes; Vincent Lisowski
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-16

Review 10.  Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.

Authors:  Catherine Lozza; Isabelle Navarro-Teulon; André Pèlegrin; Jean-Pierre Pouget; Eric Vivès
Journal:  Front Oncol       Date:  2013-09-25       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.